Director, Drug Product, Technical Operations

Company: Summit Therapeutics, Inc.

Location: Oxford

Posted: April 11th, 2026

Director, Drug Product, Technical Operations

Location: Princeton, NJ or Oxford, UK onsite.

Join to apply for the Director, Drug Product, Technical Operations role at Summit Therapeutics, Inc.

About Summit

Ivonescimab, known as SMT112, is a novel, potential first-in-class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperative binding to each of its intended targets with multifold higher affinity when in the presence of both PD-1 and VEGF.

Summit has begun its clinical development of ivonescimab in non-small cell lung cancer (NSCLC), with three active Phase III trials:

Overview Of Role

We are seeking a highly experienced and strategic Director of Drug Product Technical Operations to lead late-phase clinical and commercial manufacturing activities for our bispecific antibody sterile drug product. This role is critical in supporting BLA readiness, overseeing clinical/commercial batch production, and driving process and site changes in collaboration with MSAT. The ideal candidate will bring deep expertise in biologics manufacturing, sterile drug product operations, and regulatory expectations.

Role And Responsibilities

Experience, Education And Specialized Knowledge And Skills

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.

Seniority Level

Director

Employment Type

Full-time

Job Function

Strategy/Planning and Information Technology

#J-18808-Ljbffr
Apply Now